Vacv Biotherapeutics (Uk) Limited

DataGardener
live
Small

Vacv Biotherapeutics (uk) Limited

12269783•Private Limited With Share Capital

120 Aldersgate Street, London, EC1A4JQ

Get Full Access

Visit WebsiteBook a Direct Call
Incorporated

18/10/2019

Company Age

7 years

Directors

3

Employees

8

SIC Code

72110

Risk

low risk

Company Overview

Registration, classification & business activity

Vacv Biotherapeutics (uk) Limited (12269783) is a private limited with share capital incorporated on 18/10/2019 (7 years old) and registered in london, EC1A4JQ. The company operates under SIC code 72110 - research and experimental development on biotechnology.

Private Limited With Share Capital
SIC: 72110
Small
Incorporated 18/10/2019
EC1A4JQ
8 employees

Financial Overview

Total Assets

£958.5K

Liabilities

£3.89M

Net Assets

£-2.93M

Est. Turnover

£520.0K

AI Estimated
Unreported
Cash

£42.5K

Key Metrics

8

Employees

3

Directors

3

Shareholders

Board of Directors

3
Y
yaohe wang
director
G
glyn owain edwards
director
N
nicholas robert lemoine
director

Filed Documents

25
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:30-09-2026
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:03-07-2026
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:22-10-2025
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:17-09-2025
Notification Of A Person With Significant Control Statement
Category:Persons With Significant Control
Date:28-10-2024
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:18-10-2024
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:18-10-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:17-09-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:28-10-2023
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:26-09-2023
Change Account Reference Date Company Previous Extended
Category:Accounts
Date:15-07-2023
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:15-11-2022
Confirmation Statement With Updates
Category:Confirmation Statement
Date:20-10-2022
Accounts With Accounts Type Dormant
Category:Accounts
Date:01-09-2022
Capital Allotment Shares
Category:Capital
Date:27-06-2022
Memorandum Articles
Category:Incorporation
Date:23-05-2022
Resolution
Category:Resolution
Date:23-05-2022
Capital Allotment Shares
Category:Capital
Date:11-05-2022
Certificate Change Of Name Company
Category:Change Of Name
Date:11-05-2022
Change Of Name Notice
Category:Change Of Name
Date:11-05-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:06-05-2022
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:30-10-2021
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:11-08-2021
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:23-11-2020
Incorporation Company
Category:Incorporation
Date:18-10-2019

Innovate Grants

1

This company received a grant of £359196.0 for Treatment Of Metastatic Colorectal Cancer Deliverable Oncolytic Vaccinia Virus (Vacv002-Td-Il10D-Enpp1) For Treatment Of Metastatic Colorectal Cancer.. The project started on 01/09/2024 and ended on 31/07/2026.

Risk Assessment

low risk

International Score

Future Factor

fair

Performance Rating

Accounts

Typetotal exemption full
Due Date30/09/2027
Filing Date03/07/2026
Latest Accounts31/12/2025

Trading Addresses

120 Aldersgate Street, London, EC1A4JQRegistered

Related Companies

10
oxsonics limited
live
summit therapeutics limited
live
oxford cancer biomarkers limited
live
pancreatic cancer uk
live
bioindustry association
live
mitorx therapeutics limited
live
orthoson limited
live
association of medical research charities
live
summit (oxford) limited
live
discuva limited
live

Contact

120 Aldersgate Street, London, EC1A4JQ